0228-2027
Generic: alprazolam
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
alprazolam
Labeler
actavis pharma, inc.
Dosage Form
TABLET
Active Ingredients
alprazolam .25 mg/1
Identifiers & Regulatory
Product NDC
0228-2027
Product ID
0228-2027_dbc7e735-4b06-4747-bdce-2e9095e3a036
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2015-07-30
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
02282027
Hyphenated Format
0228-2027
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
alprazolam (source: label)
Generic Name
alprazolam (source: ndc)
Application Number
ANDA074342 (source: label)
Routes
source: label
Resolved Composition
Strengths
- .25 mg/1
Packaging
- 77000 TABLET in 1 BAG (0228-2027-00)
- 92304 TABLET in 1 CONTAINER (0228-2027-77)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "dbc7e735-4b06-4747-bdce-2e9095e3a036", "openfda": {}, "finished": false, "packaging": [{"description": "77000 TABLET in 1 BAG (0228-2027-00)", "package_ndc": "0228-2027-00", "marketing_start_date": "30-JUL-15"}, {"description": "92304 TABLET in 1 CONTAINER (0228-2027-77)", "package_ndc": "0228-2027-77", "marketing_start_date": "17-JAN-24"}], "product_id": "0228-2027_dbc7e735-4b06-4747-bdce-2e9095e3a036", "dosage_form": "TABLET", "product_ndc": "0228-2027", "dea_schedule": "CIV", "generic_name": "Alprazolam", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "ALPRAZOLAM", "strength": ".25 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20150730", "listing_expiration_date": "20261231"}